Abstract. Longitudinal assessment of the course of major psychiatric disorders has been advanced by studies from onset, but only rarely have large numbers of patients with a range of psychotic and major affective disorders been studied simultaneously and systematically from illness-onset. The decade-long McLean-Harvard First Episode Project & International Consortium for Bipolar Disorder Research has systematically followed-up large numbers of patients with DSM-IV bipolar or psychotic disorders from firsthospitalization. Major findings among patients with bipolar I disorder include: [a] full functional recovery from initial episodes was uncommon, and full symptomatic recovery, much slower than early syndromal recovery; [b] risks of relapse, recurrence, and switching were very high in the first two years; [c] most early morbidity was depressive-dysphoric, as reported in mid-course; [d] initial depression or mixed-states predicted more later depressive and overall morbidity, whereas initial mania or psychosis predicted later mania and a better prognosis; [e] based on within-subject modeling, most patients did not show progressive cycling over time, and illness-course was rather chaotic within and among patients; [f] treatment-latency or episode-counts were unassociated with responsiveness to long-term mood-stabilizing treatment; [g] very high rates of suicidal behavior and accidents occurred early; [h] early substance-use comorbidity associated with anxiety; [i] factor-analysis of prodromal symptoms predicted bipolar disorder much better than non-affective psychotic disorders. Project findings indicate that the course of bipolar I disorder is much less favorable than had been believed formerly, despite clinical treatment with modern mood-stabilizing and other treatments.
INTRODUCTION

Longitudinal studies of psychotic disorders
Many studies have sought to define the course of major psychiatric disorders and identify outcome predictors. Most have involved patients considered to have schizophrenia, usually in mid-course, and very few have compared mood and nonaffective psychotic disorders, or followed patients prospectively from illness-onset (Beiser et ai, 1988; Erickson et ai, 1989; Leff et ai, 1992; Tohen et al., 1990a; Bromet et ai, 1996; Craig et al., 1997) . Such studies have yielded inconsistent findings, owing in part to mixing subjects who differ diagnostically, by illness-duration, and in effects of uncontrolled treatments (Zis & Goodwin, 1979; Tohen, 1991) . The complexity and risk of confounding under such con-ditions has encouraged prospective studies of firstepisode patients in early or prodromal phases of illness. Most first-episode studies involve patients diagnosed with early (Jones & Tarrant, 1999; McGorry et al., 2000; Cannon et al., 2001; Gaebel et al., 2001; Hollis 2003) , or established schizophrenia (Kane et al., 1982; Biehl et al., 1986; Schubart et al., 1986; McCreadie et al., 1989; Johnstone et al, 1990; Tohen et al., 1990b; 1992a; 1996; Tohen 1991; Leff et al., 1992; Ram et al., 1992; Ventura et al., 1992; Lieberman et ai, 1993; Bromet et al., 1996; Varma et al., 1996; Craig et al., 1997; Gupta et al., 1997; Lay et al., 1997) . There have been far fewer first-episode follow-up studies of patients diagnosed with bipolar disorder (Tohen et al., 1990b (Tohen et al., , 2000a Fennig et al., 1996; Strakowski et al., 1998; Conus et al., 2004; Schimmelmann et al., 2005) , or other types of psychotic disorders (Pillmann et ai, 2002; Schimmelmann et ai, 2005; Abe et ai, 2006; Emsley et ai, 2006; 2007) .
Follow-up studies beginning early in the evolution of chronic or recurrent illnesses, and comparisons of affective vs. non-affective psychotic syndromes promise early identification of specific disorders, of clinical or biological factors associated with vulnerability or early morbidity, and may predict later illness-course and outcome (McGorry et ai, 1998; Tohen et ai, 2003; Meagher et ai, 2004) . Early studies are much less likely to be confounded by effects of chronic illness and disability, artifacts of altered life-styles, institutionalization, poor nutrition, or changes produced by long-term treatment or effects of commonly comorbid substance abuse.
Longitudinal studies in bipolar disorder
Mapping the course of bipolar disorders systematically from onset, through their typically complex and variable patterns of recurrence is a critical research challenge (Goodwin & Jamison, 1990; Kessler et al, 1997; Akiskal etai, 2000; Geddes & Goodwin, 2001; Strakowski etai, 2001; Tohen & Angst, 2002) . Documenting the course of bipolar disorders requires reliable and clinically meaningful definitions of specific phases of illness, ideally based on operational criteria that facilitate comparisons across studies and support generalization of findings (Tohen et al, 1990a,b; 1992a,b; Keller et al, 1993; Winokur ef a/., 1994; Keeker al, 1995; Strakowski etai, 2001; Chengappa et al, 2005; Conus et al, 2006; Harvey, 2006; Mclntyre et al, 2006; Shi et al, 2006) . Bipolar disorders not only have high risks of multiple recurrences as well as sustained morbidity, but also very high rates of comorbidity with substance-use and anxiety disorders, variable disability, and premature mortality from extraordinarily high suicide rates as well as adverse outcomes of medical illness (Tsuang et al, 1980; Goodwin & Jamison, 1990; Tondo et al, 2003a; Fenn et al, 2005) . To develop and implement sound and evidence-based clinical and public policies for treating bipolar disorder patients with scarce resources, much more information is required concerning their course and morbidity, ideally as early as possible to facilitate predictions.
Longitudinal studies in bipolar disorder have included patients who vary greatly in the stages of their illnesses and numbers of prior episodes. Moreover, following subjects only in midcourse of illness risks enriching research samples with relatively unstable, poor-prognosis patients (Keller et al, 1986; Keck et al, 1998; Bauer et al, 2001; Goldberg & Harrow, 2004; Nehra et al, 2006; Green, 2006; Keck, 2006) . Very few studies have enrolled bipolar disorder patients from first-episodes (Tohen et al, 1990b; Husted et al, 1995; Fennig et al, 1996; Strakowski et al, 1998; Conus et al, 2004; Schimmelmann et al, 2005) , and even fewer have followed subjects prospectively from prodromal phases preceding major episodes meeting contemporary clinical or research diagnostic criteria (Thompson et al, 2003; Amminger et al, 2006) . Even among first-episode studies, very few have involved large numbers of subjects followed-up systematically over many years Tohen et al, 2003; Conus et al, 2004; Schimmelmann et al, 2005) .
Most longitudinal studies of bipolar-disorder patients have focused on initial syndromal outcomes, later recurrence frequency, or cycle-length (Tsuang et al, 1981; Black et al, 1988; Winokur & Kadrmas, 1989; Harrow et al, 1990; Coryell et al, 1993; Winokur et al, 1994; Goldberg et al, 1995; Kessing et al, 1998; 2004; Angst & Sellaro, 2000; Angst et al, 2003) . Emerging improvements include operationally-defined measures of recovery based on modern diagnostic criteria, and distinction of syndromal from symptomatic or functional recovery (Keller et al, 1986; Tohen & Goodwin, 1995; Keck etai, 1998; Tohen etai, 1992a,b; 2000a, b; 2003; Strakowski et al, 1998) .
Recent longitudinal studies of bipolar disorder patients have challenged some traditional views of manic-depressive illnesses as disorders of favorable prognosis, in contrast to schizophrenia and other chronic, nonaffective psychotic disorders (Tohen et al, 1990a; Harrow et al, 1990; Coryell et al, 1990; Gitlin et al, 1995; Goldberg et al, 1995; Keck et al, 1998) . Even with access to modern mood-stabilizing and other treatments, most bipolar disorder patients experience high levels of morbidity, accounting for more than 40% of weeks of long-term follow-up, most of which is accounted for by depressive-dysthimic illness (Judd et al, 2002; Post et al, 2003; Baldessarini et al, 2004b; Joffe et al, 2004) . Potentially more favorably, other findings challenge the proposal first made by Kraepelin that manic-depressive disorders are typically progressive, with routinely shortening wellness-intervals between increasingly frequent recurrences (Roy-Byrne et al, 1985; Haghighat, 1996; Turvey et al, 1999; Baldessarini et al, 2004a) . Still other studies find evidence that latency from illness-onset to long-term prophylactic treatment and pretreatment recurrence counts do not necessarily limit response to longterm treatment with mood-stabilizers Bratti et al, 2003; Baldessarini et al, in press ).
The McLean-Harvard First-Episode Project
Given this background indicating the need for additional longitudinal assessments of patients with bipolar I and other disorders evaluated longitudinally from onset by standardized methods over long periods, we organized the McLean-Harvard First Episode Project in the late 1980s, led by Mauricio Tohen. This project has followed patients presenting with first-lifetime manic or psychotic illnesses, prospectively and systematically, to clarify the future course of illnesses from early stages, and to characterize such patients before potential artifacts associated with prolonged illness and treatment have intervened (Tohen et al, 1990a,b; 1992a,b; 2000a,b) . In this naturalistic investigation, treatment was managed by treating physicians and not controlled by the investigators, although we collected information about treatment systematically.
The study cohort includes nearly 400 subjects who presented in a first-lifetime episode of psychotic illness in 1989-1995 at McLean Hospital in Belmont, Massachusetts, the largest psychiatric teaching hospital affiliated with Harvard Medical School. Diagnosis was based on a bestestimate procedure at intake and again at 24 months, using all available information (SCID-P, clinical records, and interviews of family members and primary clinicians; Tohen et ah, 2000a,b) . Approximately 300 subjects met SCID-based DSM-IV criteria (updated, as required, from DSM-IIIR) for major affective disorders with psychotic features, including bipolar disorder and major depressive disorder; others were diagnosed with non-affective psychotic disorders including schizophrenia, delusional, schizophreniform, brief, or unspecified psychotic disorders. The sample is broadly inclusive of disorders, socioeconomic backgrounds, presentations, and outcomes.
In addition to detailed information about first symptoms, syndromes, and treatments obtained from subjects and family members, demographic and many clinical variables were recorded at baseline, including medical, psychiatric, and substance use comorbidity history, premorbid and current occupational and residential status. Symptoms and their severity at intake and during followup were rated with a version of the Brief Psychiatric Rating Scale [BPRS] expanded to 35 items to include symptoms of affective as well as psychotic disorders, as well as a range of other standard clinical rating instruments (Tohen et al, 2000a,b; 2003) . Data obtained during regular follow-up interviews included changes in social and demographic status, and details concerning the week-by-week course of the primary and comorbid disorders, with best-estimates of new diagnoses and approximate initial and final weeks of illness recurrences and major exacerbations. We also collected a comprehensive, systematic, and detailed inventory of specific psychopathological features present in prodromal, symptomatic, and recovered phases, supported by the 100-item Manual for the Assessment and Documentation of Psychopathology (AMDP; Guy & Ban, 1982 ) and 66-item Bonn Scale for Assessment of Basic Symptoms (BSABS; Gross et ah, 1987; Klosterkotter et ah, 2001) .
Major Findings
Our First Episode Project involves the largest reported sample of DSM-IV bipolar I disorder patients (N=173) followed-up prospectively and systematically under naturalistic conditions through nearly five years after firstlifetime psychiatric hospitalization. Patient-recruitment (72%) and retention (87%) were high, and the naturalistic conditions permit realistic evaluation of contemporary clinical outcomes with reasonable expectation of generalizability, at least to patients with mental illnesses requiring early hospitalization.
Impact of duration of initial hospitalization
Administrative and economically driven changes in length-of-hospitalization in the 1990s led to gradual shortening, from approximately six weeks initially to 1-2 weeks by the mid-1990s, and even shorter stays currently. With shortening hospitalization, average annual improvements in expanded-BPRS ratings of morbidity between admission and discharge also declined across diagnostic groups. When patients were assessed at six and 12 months later, their clinical status and level of improvement were remarkably little affected. This finding suggests that clinical improvement initiated in the hospital continued during ambulatory aftercare, but with unmeasured impact of rising average residual morbidity on patients, their families and communities (Tohen et ah, 2003; Baldessarini et ah, in preparation) .
Recovery from index manic or mixed bipolar disorder episodes
For bipolar I patients, syndromal recovery from index first-episodes of mania or mixed-states was relatively rapid (median, 5.6 weeks), and 98% no longer met DSM-IV diagnostic criteria for an acute major illness episode by 24 months following their first-lifetime hospitalization. Syndromal recovery was earlier after relatively brief initial hospitalization, among women, and with lower initial depression ratings, use of lithium, and non-use of antidepressants, suggesting an unfavorable impact of depressive features. As expected (Chengappa et ah, 2005) , full symptomatic recovery was much less often achieved: only 72% of patients were symptomatically well at 24 months.
Even more strikingly, recovery of within-subject premorbid functional levels, based on assessments of occupational status and level of independent living, was not attained by 61% of bipolar I patients at six months, nor by 57% even by 24 months, when only 43% had returned to baseline functioning; another 13% achieved functional recovery within the first year and lost it by two years (Tohen et ah, 2003) . Functional recovery at two years was more likely among older patients and after shorter initial hospitalization. These low rates of functional recovery early in the course of bipolar I disorder were unexpected, and indicate high levels of symptomatic morbidity and dysfunction very early in this supposedly "good-prognosis" disorder, despite clinical application of modern treatments. They also accord closely with other findings, in which only 35% of initially first-mania patients were functionally recovered by 12 months (Strakowskiefa/., 1998).
Early risks of new illness episodes in bipolar disorder patients
We considered the risk and timing of new episodes of illness in the bipolar I disorder patients involving relapses (return to full syndromal illness of the same type) or switches (new episodes of major depression) without full initial recovery from index manic episodes sustained for at least two months, as well as recurrences (new episodes of illness of any polarity). Relapses, switches, or recurrences occurred in 57% of bipolar I patients within two years of intake (Tondo et al, 2003b; Harvey, 2006; Shi et al, 2006) . These risks are consistent with reported failurerates of 39%-52%/year during various maintenance treatments in bipolar I patients (Gitlin et al, 1995; Goldberg et al, 1995; Baldessarini etal, 2000; Maj etal, 2001; Tondo et al, 2001; Tsai et al, 2001; Judd et al, 2002) .
Several factors differentially predicted new episodes of mania, including initial mood-congruent psychotic features, low premorbid occupational status, and lack of prominent initial depressive features. New major depression was associated with higher occupational achievement (possibly related to early demoralization), initial mixeddysphoric states, and psychiatric or medical comorbidity. Other studies have found that mixed-dysphoric index episodes (Keller et al, 1986; Tohen et al, 1990b) , comorbidity (Tohen et al, 1990b; Goldberg et al, 1995) , and psychotic features (Tohen et al, 1990b; 1992b; Coryell et al, 1990; Fennig et al, 1996; Carlson et al, 2000; Tsai et al, 2001 ) associated with poorer outcomes in bipolar disorder patients. We also noted somewhat earlier recovery and longer stability among those treated with lithium, and least favorable outcomes among those given an antidepressant (Tohen et al., 2003) . Overall, these initial findings from the very beginnings of bipolar I disorder, encourage earlier case-finding and intervention, with much greater emphasis on depression and functional recovery during close and continuous clinical aftercare.
Early morbidity during follow-up of bipolar disorder patients
Morbidity during long-term follow-up was very similar to that reported in mid-course studies (Judd et al, 2002; Post et al, 2003; Joffe et al, 2004) , in that depression-dysthymia-dysphoria were dominant mood-states, accounting for nearly 30% of weeks of follow-up, despite use of modern mood-stabilizing and antidepressant treatments (Baldessarini et al, 2004b) . The remarkably consistent mid-course and early longitudinal observations indicate that bipolar depressive illness remains a major unsolved problem. This phase of bipolar illness is of particular significance in that it is associated with substance abuse, disability, and premature mortality due to suicide or medical illnesses (Tondo et al, 2003a; Carney & Jones, 2006; Newcomer, 2006) . Moreover, it remains the least well studied type of depressive illness, for which very few treatments are proved safe and effective (Ghaemi et al, 2003; 2004; Baldessarini, 2005; Goodnick, 2007) .
We also found that the polarity of the initial episode in bipolar I disorder illness strongly predicted the type and amount of later morbidity: those starting in depressive or mixed-dysphoric states were more ill overall, and spent much more time later in depressive-dysphoric illness, whereas those who began in mania spent more time manic-hypomanic or psychotic.
Course of early bipolar disorder
Our review of research on the course of bipolar and other forms of manic-depressive disorders over the past century found highly inconsistent evidence for Kraepelin's proposed course-progression or increasing cycling-rate over time, even when the methods employed avoided the problem of enriching subsamples involving high recurrence counts with patients who cycle more rapidly than others (Oepen et al, 2004; Salvatore et al, in preparation) .
We also assessed the course of bipolar I disorder among the first-episode bipolar disorder patients by a within-subject regression method to generate individual slope functions (cycle-length vs. episode count). We found a virtually random distribution of slopes, with increasing cycling rate in only 30%^t0% of subjects (Baldessarini et al, 2004a; in preparation) . This finding may reflect effects of modern treatments, but it is consistent with other studies finding that acceleration of cycling occurs in only a minority of manic-depressive patients (Salvatore et al, in preparation) .
Lack of a routinely worsening course of bipolar illness over time accords with other findings of our Research Consortium concerning effects of illness-history on treatment-response. Findings from published studies as well as original research support the conclu-sion that, although prolonged untreated morbidity can have a devastating impact on bipolar disorder patients, evidence that response to eventual long-term mood-stabilizing treatment is compromised by either delay of treatment or more previous recurrences was lacking Bratti et al, 2003; Baldessarini et al, in press ).
Suicidal risk in early bipolar disorder
Since depression is the dominant morbidity in early and later phases of bipolar disorder, as noted, we have been particularly interested in risks of suicidal behaviors early in the course of the illness. Early suicidal behavior as well as accidents were strongly associated with the excess of depressive morbidity found early in the course of treated bipolar disorder (Khalsa et al., in press) . A majority (59%) of first-episode bipolar I disorder patients were suicidal at some time during an average of 4.2 years at risk (14.0%/year: suicidal ideation at 9.8%/year, attempts at 4.2%/year, and suicides at 0.11%/year). This observed suicide rate is 10-times above the US general population incidence (0.011%/year), and the rate of attempts (4.2%/year) is 14-times above the estimated general population attempt rate (ca. 0.3%/year; Baldessarini et al., 2006) . Adding risk of accidents increases the total observed rate of violent fatalities to 0.22%/year. The rate of accidental deaths alone (0.11 %/year) is three-times above the current US national rate of 0.037%/year. Moreover, 60% of accidents were associated with suicidality, suggesting a crucial subgroup among recent-onset bipolar I disorder patients at particularly high risk of violent self-injury or death.
Risk-factors found to be independently associated with violence, based on multivariate analysis, included greater mixed-dysphoric morbidity, presenting manic (accidents) or mixed episodes (suicidality), more time manic in follow-up (accidents), alcohol abuse, and previous suicide attempts (suicides and attempts). Similar suicidal risk factors have been identified previously, but later in the mid-course of bipolar disorders (Tsai et al., 2001; Tondo et al, 2003a; Dunner, 2004; Slama et al, 2004; Baldessarini et al, 2006) .
In parallel collaborative studies within our Research Consortium found not only that suicidal risk was much higher among bipolar than recurrent major depression outpatients, but also that nearly one-third of suicidal acts in bipolar I and II disorder patients occurred within the first year of illness (Tondo et al, 2003a; in review) .
Early substance abuse in bipolar disorder
We evaluated the early emergence of substance-use comorbidity among bipolar I patients and found anxiety symptoms to be strongly associated with abuse of alcohol and other central depressants, as well as evidence that abuse of alcohol tends to precede and coincide with depression, and that abuse of stimulants tends to coincide with or follow mania (Baethge et al, 2005; .
Early prodromal symptoms of psychotic and bipolar disorders
We recently analyzed patterns of early symptoms among a broad range of first-episode patients later proving to have DSM-IV psychotic affective or non-affective disorders, using factor-analytic methods (Salvatore et al, 2007) . Clusters of early symptoms predicted later separation between affective and nonaffective disorders, generally, but relatively poorly distinguished particular nonaffective disorders. Psychopathological features of early morbidity in psychotic disorders were statistically well accommodated by four "Factors" associated with particular prodromal symptom-clusters: Factor I was considered to represent mania with psychosis; II a mixed depressive-agitated state; III an excited-hallucinatorydelusional state; IV a disorganized-catatonic-autistic state. Factors I and III were associated with mania, Factor II with major depression or bipolar mixed-state, Factor III was less likely to be found in association with delusional disorder, and Factor IV was positively associated with major depression and negatively with mania. Based on final diagnostic categorizations after two years of followup and consideration of all available data, presence of Factors I and II predicted later affective diagnoses, whereas absence of Factor I features predicted non-affective diagnoses, and no Factor predicted later schizoaffective diagnoses. This dimensional approach to psychopathology appears to be effective in identifying and subtyping affective psychotic disorders early in their clinical evolution, whereas nonaffective-schizoaffective conditions appear to be more complex or unstable entities.
CONCLUSIONS
This summary of recent research findings from the McLean-Harvard First Episode Project and International Consortium for Bipolar Disorder Research yields several insights concerning the course of bipolar I disorder in patients followed for several years from illness onset.
These include verification that full symptomatic recovery of first-lifetime manic or mixed-state episodes was much slower, and less likely, than early syndromal recovery. In addition, only a minority of first-episode bipolar disorder patients attained functional recovery to premorbid baseline levels of occupation and independent living, even after two years from onset. Risks of relapse, switching and recurrence were very high early in the course of bipolar disorder, despite access to modern clinical treatments. In accord with recent longitudinal studies of bipolar disorder patients in mid-course, most early morbidity was depressive-dysphoric. Moreover, initial depression or mixed states predicted slower recovery, later depressive illness, and greater overall morbidity, whereas initial mania or psychosis predicted later mania and better prognosis.
Based on within-subject analysis, the distribution of illness course-trends was nearly random. Only a minority of patients showed progressive cycle-acceleration, a nearly equal proportion showed slowing, and most showed a random pattern as episode counts rose. We also found that treatment delay and episode-counts were unpredictive of responsiveness to long-term mood-stabilizing treatment, as measured by morbidity during treatment. Moreover, apparently greater relative improvement of morbidity by earlier intervention may reflect an artifact of greater morbidity proximal to the start of maintenance treatment.
A particularly important finding is that suicidal behavior and accidents were prevalent within the first several years of bipolar illness, including a third of long-term suicidal acts within the first year of illness. Substance-use comorbidity, a risk factor for suicide and attempts in bipolar disorder patients, also emerged early, particularly in association with anxiety, and with a strong association of depression with alcohol-abuse. These several findings are particularly ominous in that latency to diagnosis and establishment of long-term prophylactic treatment in bipolar disorder patients is typically delayed by 5-10 years: clearly, earlier diagnosis and intervention are required. Earlier diagnosis and prognosis may be supported by analyses of prodomal and other early symptom-patterns.
In short, findings from the past decade of studies in the First-Episode Project and the International Consortium for Bipolar Disorder Research based at McLean Hospital and Harvard Medical School indicate that the nature and course of bipolar I disorder are much less favorable than had been proposed formerly, despite access to effective mood-stabilizing and other treatments. Our findings strongly encourage earlier diagnosis of bipolar disorder and long-term protective treatment interventions aimed at limiting morbidity, dysfunction, and mortality associated with this prevalent, often disabling, and life-threatening disorder.
